![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, October 30, 2015 6:07:53 PM
1. Bring MANF into clinic for parkinsons/Alzheimer's forget Retinitis pigmentosa
2. Remove ESS. This company is a neurology company. ESS is dermatological indication. company should stick with what it's good at in neuro space
3. Reduce costs substantially. Too much stuff in the pipeline that is fluff and adds no value, and takes up a lot of money. Cutdown the pipeline to only few programs. Advance those straight to phase 3 for value creation
4. Get rid of the CEO. Unfortunately as long as Gerald's father is on the BOD that wont' happen.
Until the majority of the stuff listed above happens this will continue to fall
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM